Identification |
Name: | 1H-Benzimidazole,2-[(S)-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]- |
Synonyms: | 1H-Benzimidazole,2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-, (S)-;(-)-Lansoprazole;(S)-2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole;(S)-2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole;(S)-Lansoprazole; Levolansoprazole |
CAS: | 138530-95-7 |
Molecular Formula: | C16H14 F3 N3 O2 S |
Molecular Weight: | 0 |
InChI: | InChI=1/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)/t25-/m0/s1 |
Molecular Structure: |
|
Properties |
Flash Point: | 289.9°C |
Boiling Point: | 555.8°Cat760mmHg |
Density: | 1.5g/cm3 |
Refractive index: | 1.635 |
Flash Point: | 289.9°C |
Usage: | The S-enantiomer of Lansoprazole; a gastric proton pump inhibitor. An antiulcerative |
Safety Data |
|
|